58 related articles for article (PubMed ID: 10027004)
1. [Clinicopathological analysis of papillary thyroid carcinoma in adults with receptor tyrosine kinase rearrangement].
Liu YX; Gu HY; Li GQ; Li D; Wang JN; Li XQ; Kong WM; Wang JG
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):390-392. PubMed ID: 38556825
[No Abstract] [Full Text] [Related]
2. Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancer.
Weier HU; Ito Y; Kwan J; Smida J; Weier JF; Hieber L; Lu CM; Lehmann L; Wang M; Kassabian HJ; Zeng H; O'Brien B
Genes (Basel); 2011 Sep; 2(3):397-419. PubMed ID: 22096618
[TBL] [Abstract][Full Text] [Related]
3. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
[TBL] [Abstract][Full Text] [Related]
4. The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid.
Ruco L; Scarpino S
Biomedicines; 2014 Oct; 2(4):263-274. PubMed ID: 28548071
[TBL] [Abstract][Full Text] [Related]
5. Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study.
Mohammad Khanlou Z; Pouladi N; Hosseinpour Feizi M; Pedram N
Asian Pac J Cancer Prev; 2017 Apr; 18(4):1133-1138. PubMed ID: 28547953
[TBL] [Abstract][Full Text] [Related]
6. RET polymorphisms might be the risk factors for thyroid cancer.
Huang RX; Yang F
Int J Clin Exp Pathol; 2015; 8(5):5793-7. PubMed ID: 26191299
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor in cancer cell death and survival.
Molloy NH; Read DE; Gorman AM
Cancers (Basel); 2011 Feb; 3(1):510-30. PubMed ID: 24212627
[TBL] [Abstract][Full Text] [Related]
8. Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line.
Tartari CJ; Donadoni C; Manieri E; Mologni L; Mina PD; Villa A; Gambacorti-Passerini C
Am J Cancer Res; 2011; 1(6):716-25. PubMed ID: 22016822
[TBL] [Abstract][Full Text] [Related]
9. Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation.
Musholt TJ; Schönefeld S; Schwarz CH; Watzka FM; Musholt PB; Fottner C; Weber MM; Springer E; Schad A
Langenbecks Arch Surg; 2010 Sep; 395(7):877-83. PubMed ID: 20640859
[TBL] [Abstract][Full Text] [Related]
10. Trk receptor expression and inhibition in neuroblastomas.
Brodeur GM; Minturn JE; Ho R; Simpson AM; Iyer R; Varela CR; Light JE; Kolla V; Evans AE
Clin Cancer Res; 2009 May; 15(10):3244-50. PubMed ID: 19417027
[TBL] [Abstract][Full Text] [Related]
11. Mapping of melanoma modifier loci in RET transgenic mice.
Dragani TA; Peissel B; Zanesi N; Aloisi A; Dai Y; Kato M; Suzuki H; Nakashima I
Jpn J Cancer Res; 2000 Nov; 91(11):1142-7. PubMed ID: 11092979
[TBL] [Abstract][Full Text] [Related]
12. Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.
Ladanyi M
Am J Pathol; 2000 Aug; 157(2):341-5. PubMed ID: 10934137
[No Abstract] [Full Text] [Related]
13. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
[TBL] [Abstract][Full Text] [Related]
14. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
15. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma.
Bongarzone I; Fugazzola L; Vigneri P; Mariani L; Mondellini P; Pacini F; Basolo F; Pinchera A; Pilotti S; Pierotti MA
J Clin Endocrinol Metab; 1996 May; 81(5):2006-9. PubMed ID: 8626874
[TBL] [Abstract][Full Text] [Related]
16. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
Rabes HM; Klugbauer S
Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
[TBL] [Abstract][Full Text] [Related]
18. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
